地拉罗司效果怎么样

How effective is deferasirox? According to a retrospective study in Italy, 42.7% of patients achieved a hematological response and reduced the need for blood transfusions after receiving chelation therapy with DFO or deferasirox (Enrega). There may be a dynamic, bidirectional regulatory mechanism between erythropoiesis and iron overload. On the one hand, ineffective erythropoiesis can lead to increased intestinal iron absorption through reduced hepcidin secretion by the liver. On the other hand, chelation treatment of iron overload can improve erythropoiesis, increase hemoglobin levels, and reduce clinical blood transfusions.

The therapeutic effect of Deferasirox (Enrig) is significant, but patients cannot blindly take this drug for treatment. Taking Deferasirox (Enrig) will also produce certain side effects or adverse reactions. The most common adverse reactions include: diarrhea/vomiting/headache/abdominal pain/fever/rash/increased serum creatinine, etc. Patients should undergo detailed examination before receiving deferasirox (Enrige) treatment and strictly follow the doctor's diagnosis and treatment recommendations.

Patients taking deferasirox (Enreg) should note:

Taking deferasirox (Enrige) for treatment may cause harm to the fetus, so patients should use effective contraception during treatment with this drug. Patients should inform their doctor if they are pregnant and take medication according to the doctor's diagnosis and treatment recommendations. If the patient is breastfeeding, he should stop breastfeeding immediately.

Deferasirox (Enrige) may cause a rash. Generally, the rash will disappear automatically without the need to adjust the dosage or stop taking the medication; however, patients should stop taking the medication if the condition is severe or persistent.

Deferasirox (Enreg) should not be administered concurrently with aluminum-containing antacids. And deferasirox (Enrige) cannot be combined with other iron chelation treatments.

Deferasirox should be taken once daily on an empty stomach, at least 30 minutes before a meal, at the same time each day. Patients should not chew the tablets while taking this medicine. The method of using Deferasirox (Enrige) is also very important. It is recommended that patients use the drug under the guidance of a doctor based on their own condition.

The above is an introduction to the therapeutic effects of Deferasirox (Enrige). I hope it can help everyone. If patients have other questions about the drug (drug price, purchasing channels), they can consult the medical companion travel service.